Ashley Robshaw

875 total citations
5 papers, 102 citations indexed

About

Ashley Robshaw is a scholar working on Physiology, Oncology and Psychiatry and Mental health. According to data from OpenAlex, Ashley Robshaw has authored 5 papers receiving a total of 102 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Physiology, 2 papers in Oncology and 2 papers in Psychiatry and Mental health. Recurrent topics in Ashley Robshaw's work include Alzheimer's disease research and treatments (3 papers), Dementia and Cognitive Impairment Research (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Ashley Robshaw is often cited by papers focused on Alzheimer's disease research and treatments (3 papers), Dementia and Cognitive Impairment Research (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). Ashley Robshaw collaborates with scholars based in United States. Ashley Robshaw's co-authors include David Riddell, Kevin Atchison, Stacey J. Sukoff Rizzo, Honghui Zhou, Margaret M. Zaleska, Cathleen Gonzales, Stacey L. Becker, Yasong Lu, Charles E. Nolan and Sarah M. Osgood and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Pharmacology Biochemistry and Behavior and Alzheimer s & Dementia.

In The Last Decade

Ashley Robshaw

5 papers receiving 100 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ashley Robshaw United States	4	54	32	26	20	18	5	102
Juan Bao China	5	28 0.5×	16 0.5×	6 0.2×	23 1.1×	22 1.2×	10	118
Kevin Booth United States	7	134 2.5×	72 2.3×	44 1.7×	35 1.8×	12 0.7×	17	192
Serge Pieters Belgium	6	29 0.5×	28 0.9×	26 1.0×	42 2.1×	6 0.3×	7	177
Barbara Vogg Switzerland	4	78 1.4×	37 1.2×	37 1.4×	70 3.5×	10 0.6×	8	155
Rudolph E. Tanzi United States	5	123 2.3×	29 0.9×	18 0.7×	74 3.7×	18 1.0×	14	183
Patrick Guest United Kingdom	5	25 0.5×	35 1.1×	20 0.8×	42 2.1×	3 0.2×	8	129
Gérald Luscan United States	4	36 0.7×	15 0.5×	12 0.5×	10 0.5×	7 0.4×	6	66
Ana Martinez Hernandez Germany	3	23 0.4×	34 1.1×	18 0.7×	41 2.0×	8 0.4×	4	88
Tengfei Wang United States	8	31 0.6×	12 0.4×	7 0.3×	75 3.8×	17 0.9×	18	198

Countries citing papers authored by Ashley Robshaw

Since Specialization

Citations

This map shows the geographic impact of Ashley Robshaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley Robshaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley Robshaw more than expected).

Fields of papers citing papers by Ashley Robshaw

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashley Robshaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley Robshaw. The network helps show where Ashley Robshaw may publish in the future.

Co-authorship network of co-authors of Ashley Robshaw

This figure shows the co-authorship network connecting the top 25 collaborators of Ashley Robshaw. A scholar is included among the top collaborators of Ashley Robshaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashley Robshaw. Ashley Robshaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Wood, Kathleen M., Cathleen Gonzales, Feng Pan, et al.. (2015). P4‐315: Evaluating amyloid‐beta processing using novel gamma‐secretase modulators in preclinical animal models. Alzheimer s & Dementia. 11(7S_Part_19). 1 indexed citations

2.

Gonzales, Cathleen, Margaret M. Zaleska, David Riddell, et al.. (2014). Alternative method of oral administration by peanut butter pellet formulation results in target engagement of BACE1 and attenuation of gavage-induced stress responses in mice. Pharmacology Biochemistry and Behavior. 126. 28–35. 40 indexed citations

3.

Lu, Yasong, Hugh A. Barton, Louis Leung, et al.. (2012). Cerebrospinal Fluid β-Amyloid Turnover in the Mouse, Dog, Monkey and Human Evaluated by Systematic Quantitative Analyses. Neurodegenerative Diseases. 12(1). 36–50. 18 indexed citations

4.

Lu, Yasong, David Riddell, Éva Hajós‐Korcsok, et al.. (2012). Cerebrospinal Fluid Amyloid-β (Aβ) as an Effect Biomarker for Brain Aβ Lowering Verified by Quantitative Preclinical Analyses. Journal of Pharmacology and Experimental Therapeutics. 342(2). 366–375. 24 indexed citations

5.

Lu, Yasong, Liming Zhang, Charles E. Nolan, et al.. (2011). Quantitative Pharmacokinetic/Pharmacodynamic Analyses Suggest That the 129/SVE Mouse Is a Suitable Preclinical Pharmacology Model for Identifying Small-Molecule γ-Secretase Inhibitors. Journal of Pharmacology and Experimental Therapeutics. 339(3). 922–934. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact